Rankings
▼
Calendar
DNA Q1 2023 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena
DNA
Ginkgo Bioworks Holdings, Inc.
$418M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$81M
-52.1% YoY
Gross Profit
$58M
72.3% margin
Operating Income
-$216M
-267.3% margin
Net Income
-$205M
-254.0% margin
EPS (Diluted)
$-4.29
QoQ Revenue Growth
-17.9%
Cash Flow
Operating Cash Flow
-$91M
Free Cash Flow
-$110M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$2.4B
Total Liabilities
$810M
Stockholders' Equity
$1.6B
Cash & Equivalents
$1.2B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$81M
$168M
-52.1%
Gross Profit
$58M
$83M
-29.7%
Operating Income
-$216M
-$675M
+68.1%
Net Income
-$205M
-$591M
+65.3%
Revenue Segments
Service
$35M
75%
Product
$12M
25%
← FY 2023
All Quarters
Q2 2023 →